Filing Flows

Filing Flows › Prestige Consumer Healthcare (PBH) › Q1 FY27 › vs Q4 FY26

Prestige Consumer Healthcare (PBH) Q1 FY27 vs Q4 FY26 (quarter over quarter)

Prestige Consumer Healthcare's revenue fell $15.9M (-6%) from $282M in Q4 FY26 to $266M in Q1 FY27. Gross margin 51.3% against 51.9% (-0.7 pts).

Prestige Consumer Healthcare, Q1 FY27: revenue $266M (+6% year over year), operating margin 19.8%, net earnings $29.2M, operating cash flow $70.8M. The chart draws each line against Q4 FY26, the increases inside each band.

Prestige Consumer Healthcare: what changed, Q1 FY27 vs Q4 FY26Prestige Consumer Healthcare: what changed, Q1 FY27 vs Q4 FY26Working capital & other$51.0MFree cash flow (OCF − capex)$29.5MOperating cash flow$27.9MPre-tax earnings−$26.2MNet earnings−$24.8MOperating profit−$23.0MGeneral & admin$13.0MOperating expenses$12.9MGross profit−$10.1MCost of revenue−$5.8M

Margins

Q1 FY27Q4 FY26Change
Gross margin51.3%51.9%-0.7 pts
Operating margin19.8%26.8%-7.0 pts
Net margin11.0%19.1%-8.2 pts
Free cash flow margin25.2%13.4%+11.9 pts

Every line

LineQ1 FY27Q4 FY26Change%
Revenue$266M$282M−$15.9M-6%
Gross profit$136M$146M−$10.1M-7%
Cost of revenue$130M$135M−$5.8M-4%
Operating profit$52.5M$75.5M−$23.0M-30%
Operating expenses$83.7M$70.8M$12.9M+18%
Pre-tax earnings$38.5M$64.8M−$26.2M-40%
Other expense, net$14.0M$10.7M$3.3M+30%
Sales & marketing$34.7M$35.1M−$421K-1%
General & admin$43.3M$30.3M$13.0M+43%
Other operating costs$5.7M$5.4M$259K+5%
Net earnings$29.2M$53.9M−$24.8M-46%
Income tax$9.4M$10.8M−$1.5M-14%
Depreciation & amortization$8.8M$8.4M$401K+5%
Share-based compensation$4.0M$2.6M$1.3M+51%
Working capital & other$28.9M−$22.1M$51.0M—
Operating cash flow$70.8M$42.8M$27.9M+65%
Free cash flow (OCF − capex)$67.1M$37.6M$29.5M+78%
Capital expenditures$3.7M$5.2M−$1.5M-29%

Questions

How much did Prestige Consumer Healthcare's revenue grow quarter over quarter in Q1 FY27?

Prestige Consumer Healthcare's revenue fell $15.9M (-6%) from $282M in Q4 FY26 to $266M in Q1 FY27. Gross margin 51.3% against 51.9% (-0.7 pts).

Q1 FY27 results → · Compare in the interactive Sankey →